PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Samsara Inc. (IOT)
33.600.80 (-2.33%)
33.44 - 34.57
31.40 - 61.90
7.61M / 5.95M (Avg.)
-152.73 | -0.22
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
13.43%
Revenue growth similar to GTLB's 12.35%. Walter Schloss would see if both companies share industry tailwinds.
18.36%
Gross profit growth 1.25-1.5x GTLB's 13.02%. Bruce Berkowitz would see if strategic sourcing or brand premium explains outperformance.
72.53%
Positive EBIT growth while GTLB is negative. John Neff might see a substantial edge in operational management.
72.53%
Positive operating income growth while GTLB is negative. John Neff might view this as a competitive edge in operations.
71.92%
Net income growth above 1.5x GTLB's 43.00%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
84.62%
EPS growth above 1.5x GTLB's 43.75%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
84.62%
Diluted EPS growth above 1.5x GTLB's 43.75%. David Dodd would see if there's a robust moat protecting these shareholder gains.
82.78%
Share count expansion well above GTLB's 1.18%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
82.78%
Diluted share count expanding well above GTLB's 1.18%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
-0.99%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-3.02%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-25.39%
Negative 10Y revenue/share CAGR while GTLB stands at 167.57%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-25.39%
Negative 5Y CAGR while GTLB stands at 167.57%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-25.39%
Negative 3Y CAGR while GTLB stands at 167.57%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
39.61%
10Y OCF/share CAGR above 1.5x GTLB's 2.32%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
39.61%
5Y OCF/share CAGR above 1.5x GTLB's 2.32%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
39.61%
3Y OCF/share CAGR above 1.5x GTLB's 2.32%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
15.25%
Below 50% of GTLB's 30.96%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
15.25%
Below 50% of GTLB's 30.96%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
15.25%
Below 50% of GTLB's 30.96%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
6.09%
Below 50% of GTLB's 143.33%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
6.09%
Below 50% of GTLB's 143.33%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
6.09%
Below 50% of GTLB's 143.33%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
3.50%
Our AR growth while GTLB is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
26.99%
Inventory growth well above GTLB's 2.22%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-1.46%
Negative asset growth while GTLB invests at 0.69%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-46.76%
We have a declining book value while GTLB shows 1.17%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-4.00%
We’re deleveraging while GTLB stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-67.59%
Our R&D shrinks while GTLB invests at 11.25%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-38.21%
We cut SG&A while GTLB invests at 9.97%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.